According to JPMorgan Chase's senior medical technology analyst Mike Weinstein, the pullback presents a perfect buying opportunity for select names in the space. On CNBC's "Fast Money" on Monday, Weinstein gave his top picks in health care that ...View Complete Story
The latest must-read in financial circles is JPM boss Jamie Dimon's 32 page letter to JP Morgan Chase Chase shareholders made public last week. It is a mixture of gritty optimism going forward with rueful musings on the costly nature of regulation in ...
ForbesView Complete Story
JPMorgan Chase & Co. logo JPMorgan Chase & Co. (NYSE:JPM)'s stock had its “neutral” rating restated by research analysts at Nomura in a report released on Monday, Analyst Ratings Network.com reports. They currently have a $62.00 target price on the ...View Complete Story
JPM Shuffle: Shao Zili, JPMorgan Chase's chairman and chief executive in China, will step down from those positions and take over as vice chairman of the Asia-Pacific region as soon as a replacement is found. The unofficial official word from the bank ...View Complete Story